New pill aims to quiet arthritic knee pain
NCT ID NCT07641517
First seen Jun 12, 2026 · Last updated Jun 22, 2026 · Updated 2 times
Summary
This Phase 2 trial tests an oral drug called LY4065967 for knee pain caused by osteoarthritis. About 150 adults with chronic knee pain and confirmed arthritis will receive either the drug or a placebo. The main goal is to see if the drug safely reduces pain intensity over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Accel Research Sites - DeLand Clinical Research Unit
DeLand, Florida, 32720, United States
Contact
-
Altoona Center For Clinical Research
Duncansville, Pennsylvania, 16635, United States
Contact
-
Arizona Research Center
Phoenix, Arizona, 85053, United States
Contact
-
Artemis Institute for Clinical Research
Riverside, California, 92503, United States
Contact
-
Artemis Institute for Clinical Research
San Diego, California, 92103, United States
Contact
-
Bradenton Research Center, Inc.
Bradenton, Florida, 34205, United States
Contact
-
CMR of Greater New Haven
Hamden, Connecticut, 06517, United States
Contact
-
Central Phoenix Medical Clinic
Phoenix, Arizona, 85020, United States
Contact
-
Central Research Associates
Birmingham, Alabama, 35205, United States
Contact
-
Charter Research - Lady Lake
The Villages, Florida, 32162, United States
Contact
-
Clinvest Research LLC
Springfield, Missouri, 65807, United States
Contact
-
Conquest Research
Winter Park, Florida, 32789, United States
Contact
-
DelRicht Research
New Orleans, Louisiana, 70115, United States
Contact
-
DelRicht Research
Tulsa, Oklahoma, 74133, United States
Contact
-
Desert Oasis Healthcare Medical Group
Palm Springs, California, 92262, United States
Contact
-
FutureSearch Trials of Neurology
Austin, Texas, 78731, United States
Contact
-
Great Lakes Research Group, Inc.
Bay City, Michigan, 48706, United States
Contact
-
K2 MEDICAL Research THE VILLAGES
Lady Lake, Florida, 32159, United States
Contact
-
K2 Medical Research ORLANDO
Maitland, Florida, 32751, United States
Contact
-
Lillestol Research
Fargo, North Dakota, 58104, United States
Contact
-
Lucida Clinical Trials
New Bedford, Massachusetts, 02740, United States
Contact
-
META Medical Research Institute
Dayton, Ohio, 45432, United States
Contact
-
MedVadis Research Corporation
Waltham, Massachusetts, 02451, United States
Contact
-
Merritt Island Medical Research, LLC
Merritt Island, Florida, 32952, United States
Contact
-
New Horizon Research Center
Miami, Florida, 33165, United States
Contact
-
North Georgia Clinical Research
Woodstock, Georgia, 30189, United States
Contact
-
Northwest Clinical Research Center
Bellevue, Washington, 98007, United States
Contact
-
Northwestern University
Chicago, Illinois, 60611, United States
Contact
-
Ponce Medical School Foundation Inc.
Ponce, 00716, Puerto Rico
Contact
-
Precision Clinical Research
Sunrise, Florida, 33351, United States
Contact
-
Rainier Clinical Research Center
Renton, Washington, 98057, United States
Contact
-
Re:Cognition Health - Fort Worth
Fort Worth, Texas, 76104, United States
Contact
-
Renstar Medical Research
Ocala, Florida, 34470, United States
Contact
-
Rochester Clinical Research, LLC
Rochester, New York, 14609, United States
Contact
-
StudyMetrix Research
City of Saint Peters, Missouri, 63303, United States
Contact
-
Suncoast Clinical Research, Inc.
New Port Richey, Florida, 34652, United States
Contact
-
Suncoast Research Group
Miami, Florida, 33135, United States
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
LY4065967 (oral drug)
What this could lead to
If successful, this could provide a new oral option to ease chronic knee pain from osteoarthritis.
What could go wrong
This is an early Phase 2 trial with only 150 people. The drug may not reduce pain better than placebo, and side effects are unknown.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.